WORX News and Press, SCWorx Corp. From 06/06/20

Nasdaq notifies SCWorx (NASDAQ: WORX ) that it has not yet filed its 10-K for the fiscal year ended December 31, 2019. More news on: SCWorx Corp., Healthcare stocks news, Read more ...

NEW YORK, June 05, 2020 (GLOBE NEWSWIRE) -- SCWorx Corp. (Nasdaq: WORX) announced today that on June 1 and June 2, 2020, the Nasdaq Stock Market notified the Company that it was not in compliance with the Nasdaq’s rules for continued listing because the Company has not yet filed it...

New York, New York--(Newsfile Corp. - May 29, 2020) -  Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in SCWorx Corp. (NASDAQ: WORX) ("SCWorx" or the "Company") of the June 29, 2020 deadline to seek the role of lead plaintiff in a federal securities cl...

New York, New York--(Newsfile Corp. - May 26, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in SCWorx Corp. (NASDAQ: WORX) ("SCWorx" or the "Company") of the June 29, 2020 deadline to seek the role of lead plaintiff in a federal securities class ...

New York, New York--(Newsfile Corp. - May 11, 2020) -  Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in SCWorx Corp. (NASDAQ: WORX) ("SCWorx" or the "Company") of the June 29, 2020 deadline to seek the role of lead plaintiff in a federal securities cl...

NEW YORK, May 06, 2020 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market ® (Nasdaq: NDAQ) announced that the trading halt status in SCWorx Corp. (Nasdaq: WORX) was changed to "additional information requested" from the company. Trading in the company’s stock had been halted on April ...

Akari Therapeutics Releases Positive Top Line Data Akari Therapeutics ( AKTX ) reported encouraging results from its Phase 2 study of Nomacopan. The study met its primary endpoint which was related to no drug-related adverse events. The drug candidate was granted Orphan Drug designation ...

New York, New York--(Newsfile Corp. - May 5, 2020) -  Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in SCWorx Corp. (NASDAQ: WORX) ("SCWorx" or the "Company") of the June 29, 2020 deadline to seek the role of lead plaintiff in a federal securities cla...

In a regulatory filing , SCWorx (NASDAQ: WORX ) discloses that virtual healthcare network Rethink My Healthcare has canceled its purchase order for up to 52M COVID-19 rapid antibody tests announced on April 13. More news on: SCWorx Corp., Healthcare stocks news, Read more ...

NEW YORK, May 01, 2020 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in SCWorx Corp. (“SCWorx” or the “Company”) (NASDAQ:WORX) of the June 29, 2020 deadline to seek the role of lead plaintiff in a federal ...